Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

The Federal Drug Administration announced two different tomato recalls affecting 14 states for the possible contamination of ...

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).

The Food and Drug Administration approved the once-a-day pill ... More than 80% of women experience hot flashes during menopause, the FDA noted, as the body gradually produces lower levels of ...

FDA accepted a new drug application for nonhormonal elinzanetant to treat hot flashes associated with menopause. If approved, elinzanetant would be the second nonhormonal option for menopausal women.

"It's the first that's been FDA-approved ... approved by the Food and Drug Administration means there is also relief. "We have uncovered the neurobiology of hot flashes," University of Pittsburgh ...

Hope is on the horizon thanks to a new drug called VEOZAH approved by the FDA in May. “Many women are not able to take hormones to treat their hot flashes, and now we have a medication that is a ...

Not only do the vast majority of women experience hot flashes, but for a third of women they can last more than 10 years, Shufelt said.New FDA-approved drug availableThe most exciting addition to ...